BridgeMD
Tests treatment safety and results for Aneurysmal Subarachnoid Hemorrhage (aSAH)
Official title Efficacy of Scalp Block in Managing Post Subarachnoid Hemorrhage Headache in Critically Ill Patients. A Single Centre Randomized Controlled Trial
ClinicalTrials.gov ID: NCT07307508
What this study is testing
- What it's testing
- Subarachnoid hemorrhage (SAH) is a devastating neurological disorder associated with significant mortality and morbidity rates, arising not just from the hemorrhage itself but also because of the catastrophic multisystem sequelae that can accompany the condition. Rupture of an intracranial aneurysm accounts for up to 85% of instances of SAH, occurring in approximately 3 to 25 people per 100,000 annually in most populations.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- All adults \> 18 years who are admitted to the Surgical Intensive Care Unit (SICU) with a confirmed diagnosis of aneurysmal subarachnoid hemorrhage...
You likely can't join if
- Patients with aSAH undergoing surgical craniotomy and aneurysmal clipping.
- Non-aneurysmal subarachnoid or other intracranial hemorrhage forms (e.g., Intracerebral hemorrhage).
- SICU admission Glasgow Coma Scale (GCS) of 13 or lower.
- WFNS Score 4 / 5 or requiring mechanical ventilation for more than 24 hrs.
- Patients with known allergy to local anesthetics.
- Admission to ICU \> 7 days after hemorrhage.
See the full eligibility criteria
- All adults \> 18 years who are admitted to the Surgical Intensive Care Unit (SICU) with a confirmed diagnosis of aneurysmal subarachnoid hemorrhage, undergoing endovascular treatment of the aneurysm (coiling/flow...
- Patients with aSAH undergoing surgical craniotomy and aneurysmal clipping.
- Non-aneurysmal subarachnoid or other intracranial hemorrhage forms (e.g., Intracerebral hemorrhage).
- SICU admission Glasgow Coma Scale (GCS) of 13 or lower.
- WFNS Score 4 / 5 or requiring mechanical ventilation for more than 24 hrs.
- Patients with known allergy to local anesthetics.
- Admission to ICU \> 7 days after hemorrhage.
- Patients with a documented bleeding disorder.
- Patients with a history of chronic headache disorder or migraine.
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Doha, Qatar
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Doha, Qatar. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.